Literature DB >> 25277625

Integrated solid-phase extraction-capillary liquid chromatography (speLC) interfaced to ESI-MS/MS for fast characterization and quantification of protein and proteomes.

Lasse Gaarde Falkenby1, Gerard Such-Sanmartín, Martin R Larsen, Ole Vorm, Nicolai Bache, Ole N Jensen.   

Abstract

The high peptide sequencing speed provided by modern hybrid tandem mass spectrometers enables the utilization of fast liquid chromatographic (LC) separation techniques. We present a robust solid-phase extraction/capillary LC system (speLC) for 5-10 min separation of semicomplex peptide mixtures prior to ESI-MS/MS for peptide sequencing. This speLC-MS/MS system eliminates sample-to-sample carry-over by using disposable micropipette solid-phase extraction tips (StageTips) for peptide sample loading, concentration, and desalting. Automated analysis of 192 replicates of E. coli peptide mixtures in 30 h demonstrated the throughput, stability, and reproducibility of the system. The speLC-MS/MS system detected low-femtomole amounts of peptides and allowed sequencing of 1 μg of HeLa cells protein extracts at a rate of ∼ 90 peptides/min, identifying more than 1500 peptides (>500 proteins) in a 10 min speLC-MS/MS experiment. Analysis by selected reaction monitoring by speLC-SRM-MS/MS of distinct peptides derived from the blood proteins IGF1, IGF2, IBP2, and IBP3 demonstrated protein quantification with CV values below 10% across 96 replicates. The speLC-MS/MS system is ideally suited for fast screening and characterization of large numbers of peptide-containing samples in biological, biomedical, and clinical laboratories.

Entities:  

Keywords:  mass spectrometry; nanoliquid chromatography; protein analysis; solid-phase extraction; stagetips

Mesh:

Substances:

Year:  2014        PMID: 25277625     DOI: 10.1021/pr5008575

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  6 in total

1.  Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.

Authors:  Matthew D Dun; Robert J Chalkley; Sam Faulkner; Sheridan Keene; Kelly A Avery-Kiejda; Rodney J Scott; Lasse G Falkenby; Murray J Cairns; Martin R Larsen; Ralph A Bradshaw; Hubert Hondermarck
Journal:  Mol Cell Proteomics       Date:  2015-06-03       Impact factor: 5.911

2.  Improving the Sensitivity, Resolution, and Peak Capacity of Gradient Elution in Capillary Liquid Chromatography with Large-Volume Injections by Using Temperature-Assisted On-Column Solute Focusing.

Authors:  Rachael E Wilson; Stephen R Groskreutz; Stephen G Weber
Journal:  Anal Chem       Date:  2016-04-26       Impact factor: 6.986

Review 3.  Solid-phase extraction strategies to surmount body fluid sample complexity in high-throughput mass spectrometry-based proteomics.

Authors:  Marco R Bladergroen; Yuri E M van der Burgt
Journal:  J Anal Methods Chem       Date:  2015-01-27       Impact factor: 2.193

4.  A Double-Barrel Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) System to Quantify 96 Interactomes per Day.

Authors:  Fabian Hosp; Richard A Scheltema; H Christian Eberl; Nils A Kulak; Eva C Keilhauer; Korbinian Mayr; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2015-04-17       Impact factor: 5.911

5.  Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS.

Authors:  Yangyang Bian; Runsheng Zheng; Florian P Bayer; Cassandra Wong; Yun-Chien Chang; Chen Meng; Daniel P Zolg; Maria Reinecke; Jana Zecha; Svenja Wiechmann; Stephanie Heinzlmeir; Johannes Scherr; Bernhard Hemmer; Mike Baynham; Anne-Claude Gingras; Oleksandr Boychenko; Bernhard Kuster
Journal:  Nat Commun       Date:  2020-01-09       Impact factor: 14.919

6.  A Novel LC System Embeds Analytes in Pre-formed Gradients for Rapid, Ultra-robust Proteomics.

Authors:  Nicolai Bache; Philipp E Geyer; Dorte B Bekker-Jensen; Ole Hoerning; Lasse Falkenby; Peter V Treit; Sophia Doll; Igor Paron; Johannes B Müller; Florian Meier; Jesper V Olsen; Ole Vorm; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2018-08-13       Impact factor: 5.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.